IFNG and COVID-19: To determine whether SARS-CoV-2-specific T-cell immunity was generated and sustained in COVID-19 convalescent patients, we utilized ELISpot assay to measure the number of IFN-γ- and IL-2-secreting T cells, respectively (Figure 6A).